Literature DB >> 3378878

High-field magnetic resonance imaging of intracranial hematomas.

J M Gomori1, R I Grossman, I Steiner.   

Abstract

One hundred intracranial hematomas aged 1 day to greater than 4 years old were imaged at 1.5 Tesla using T1- and T2-weighted spin-echo pulse sequences. Characteristic intensity patterns seen in the evolution of hematomas were identical to those preliminarily reported in 20 hematomas. They allow staging of a hematoma into acute (less than 1 week old), subacute (between 1 week and 1 month old), and chronic (several months to several years old). The mechanisms suspected to be responsible for these intensity patterns were confirmed by in vitro nuclear magnetic relaxometry of blood, ferritin and hemosiderotic spleen samples performed on a variable field spectrometer at 0.19 to 1.4 Tesla. High-field magnetic resonance imaging is sensitive and specific for hemorrhage in all of its stages of evolution as well as to the ambient oxygen tension of acute hematomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378878

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  3 in total

1.  Significance of haemorrhagic lacunes on MRI in patients with hypertensive cerebrovascular disease and intracerebral haemorrhage.

Authors:  J Scharf; E Bräuherr; M Forsting; K Sartor
Journal:  Neuroradiology       Date:  1994-10       Impact factor: 2.804

2.  MR imaging of intracranial hemorrhage in neonates and infants at 2.35 Tesla.

Authors:  M Zuerrer; E Martin; E Boltshauser
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

3.  Age determination of vessel wall hematoma in spontaneous cervical artery dissection: a multi-sequence 3T cardiovascular magnetic resonance study.

Authors:  Maximilian Habs; Thomas Pfefferkorn; Clemens C Cyran; Jochen Grimm; Axel Rominger; Marcus Hacker; Christian Opherk; Maximilian F Reiser; Konstantin Nikolaou; Tobias Saam
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-28       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.